Miltel

Hiroshima, Japan Founded: 2012 • Age: 14 yrs
Telomere tests for aging detection and cellular senescence are provided.

About Miltel

Miltel is a Healthcare company based in Hiroshima (Japan) founded in 2012 by Eitoshi Tahara. Telomere tests for aging detection and cellular senescence are provided. Miltel has raised $5.28 million across 3 funding rounds from investors including Kyocera, Beyond Next Ventures and Medical Net. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Consumer Genomics. Its competitors include Lily MedTech, Cranebio and MyCode; 1 of its 3 listed competitors has raised funding.

Company details

Miltel was founded in 2012 in Hiroshima, Japan, and operates in the biotechnology sector focused on aging diagnostics. Telomere testing services are offered to measure gene strength and fatigue resulting from daily stress. These assessments assist in evaluating cellular senescence. The companys domain is mirtel.co.jp, with Eitoshi Tahara serving as founder.

  • Headquarters Hiroshima, Japan
  • Founders Eitoshi Tahara
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website mirtel.co.jp
  • Social Instagram
Key Metrics
  • Total Equity Funding
    $5.28M (USD)

    in 3 rounds

  • Investors
    Kyocera

    & 4 more

Funding Insights of Miltel

Miltel has successfully raised a total of $5.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $5.28M
  • Total Rounds 3
  • Investors Count 5

All 3 funding rounds of Miltel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2023Series A–Medical Net
–
Jun 2018$5.28MSeries A–Beyond Next Ventures, Kyocera
–
Nov 2015Seed–Ntt Docomo Ventures
–
Valuation history

5 investors in total: 5 institutional.

Investors in Miltel

Miltel has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Kyocera, Beyond Next Ventures and Medical Net.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
2014beyondnextventures.comTokyo, Japan
Hiroshima Venture Capital is engaged in venture and private equity investments.
1995h-vc.co.jpHiroshima, Japan
NTT Group backed venture capital fund
nttdocomo-v.comMinato, Japan
Kyocera is engaged in providing technology solutions globally.
1959global.kyocera.comHorse Shoe, United States
Online health information portals which provides medical and life-related information
2001medical-net.comShibuya, Japan
Premium access

Investor details for Miltel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Miltel

1 people are tracked at Miltel (1 in leadership).

NameRoleGroup
Eitoshi Tahara
FounderLeadership
Premium access

Complete people profiles for Miltel

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Miltel

3 dated milestones of Miltel across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded Miltel is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A,.

Competitors of Miltel

Miltel has 3 listed competitors in our database, 1 of them funded. They include Lily MedTech, Cranebio and MyCode.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lilymedtech.com2016Tokyo, Japan$3.31M
Ultrasound-based diagnostic imaging for breast cancer detection is developed.
crane-bio.com2021Minato, Japan
Self-service genetic test kits for women's health are developed.
mycode.jp2014Tokyo, Japan
Provides reliable genetic testing services for personalized health insights.
Premium access

Detailed competitors of Miltel

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Miltel

The website of Miltel (mirtel.co.jp) receives about 6K visits a month.

  • Monthly visits
    6K

    ▼ 58.2% vs previous month

Similar websites

Websites whose visitors overlap most with Miltel. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
isoda.or.jp
isoda.or.jp
100%
#2,345,032–
rehab.cloud
rehab.cloud
81%
#153,312–
anamne.com
81%
295.1K#151,181View details
docmisao.jp
docmisao.jp
66%
#2,095,370–
morinomiya-naishikyo.com
morinomiya-naishikyo.com
64%
#1,111,815–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 36 similar websites and full traffic analytics for Miltel

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 36 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Miltel

Frequently Asked Questions about Miltel

Miltel was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Miltel is headquartered in Hiroshima, Japan.

Miltel is a funded company, having raised a total of $5.28M across 3 funding rounds to date.

Miltel was founded in 2012 in Hiroshima, Japan, and operates in the biotechnology sector focused on aging diagnostics. Telomere testing services are offered to measure gene strength and fatigue resulting from daily stress. These assessments assist in evaluating cellular senescence. The companys domain is mirtel.co.jp, with Eitoshi Tahara serving as founder.

Miltel's top competitors include Lily MedTech, Cranebio and MyCode.

Miltel has 5 investors. Key investors include Kyocera, Beyond Next Ventures, Medical Net, Hiroshima Venture Capital, and Ntt Docomo Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available